Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.120
+0.020 (0.95%)
At close: Jun 12, 2026, 4:00 PM EDT
2.160
+0.040 (1.89%)
After-hours: Jun 12, 2026, 5:41 PM EDT

CNTB Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, CNTB stock has a consensus rating of "Strong Buy" and an average price target of $7.07. The average 1-year stock price forecast is 233.49% higher than the current stock price, while the lowest is $4.00 (+88.68%) and the highest is $10 (+371.70%).

Price Target: $7.07 (+233.49%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$4.00$7.07$7.00$10
Change+88.68%+233.49%+230.19%+371.70%

Analyst Ratings

The average analyst rating for CNTB stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy555577
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total555577

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$7
BuyReiterates$7+230.19%May 26, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Initiates
$6
BuyInitiates$6+183.02%May 26, 2026
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
$4
BuyInitiates$4+88.68%May 21, 2026
BTIG
BTIG
Buy
Maintains
$10
BuyMaintains$10+371.70%May 13, 2026
Northland Securities
Northland Securities
Buy
Maintains
$7.5
BuyMaintains$7.5+253.77%Apr 24, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
5.70M
from 64.00K
Increased by 8,811.02%
Revenue Next Year
10.74M
from 5.70M
Increased by 88.38%
EPS This Year
-0.15
from -0.14
EPS Next Year
-0.14
from -0.15
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingJan 1, 2022Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
---26.03M64.00K5.70M
Revenue Growth
-----99.75%8,811.02%
Gross Profit
---26.03M64.00K4.68M
Gross Margin
---100.00%100.00%82.00%
Operating Income
-97.66M-116.36M-69.06M-19.25M-58.07M-73.73M
Net Income
-202.27M-118.09M-62.11M-15.63M-55.48M-72.67M
EPS
-----0.14-0.15
Free Cash Flow
-46.03M-67.55M-25.55M-21.10M-30.65M-55.23M
No. Analysts
-----7
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High15.0M
Avg5.7M
Low196,887

Revenue Growth

Revenue Growth202620272028
High
23,287.2%
Avg
8,811.0%
Low
207.6%

EPS Forecast

EPS202620272028
High-
Avg-0.15
Low-

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-